Tactile Systems Technology, Inc. (TCMD)
Healthcare
- Fundamental
- 4
- Sentiment
- 3
- Technical
- 4
Do Nothing: company.price is 30.27, above the strategy's $25.00 ceiling.
Company overview
Tactile Systems Technology, Inc. develops and provides medical devices for chronic diseases in the United States. Its products include the Flexitouch Plus system for lymphedema treatment, the Entre system for at-home treatment of venous disorders, and the AffloVest for managing pulmonary secretions. The company is headquartered in Minneapolis, Minnesota.
Fundamental
goodTactile Systems Technology shows strong liquidity and growth, but moderate profitability and reimbursement risks limit its fundamental score to 4/5.
Strong liquidity and improving growth/margins with net-cash leverage; valuation looks attractive on EV multiples and DCF, but reimbursement/Medicare-policy risk and only moderate profitability keep the score at 4/5.
Sentiment
fairMedia sentiment is cautiously optimistic, but retail engagement is low, forming a watch setup rather than an actionable buy.
Near-term narrative support comes mainly from the **announced** 2026-07-13 exclusive U.S. distribution agreement for MyoSleeve (bullish), but third-party coverage is sparse/mixed and the 30–90d sentiment delta is **indeterminate** due to an insufficient valid baseline sample. Legal/investigation scans returned no regulator-confirmed probes, so no red-flag caps fired.
Technical
goodThe stock exhibits a strong bullish trend with expanding volume, but is considered extended and above the strategy's price ceiling.
On chart merit alone, TCMD scores 4/5: price closed above daily VWAP, SMA20/50/200, and EMA9/21, while MACD is positive and above signal and ADX 54.98 confirms a strong uptrend. The score stops short of 5 because RSI 75.63 and Williams %R -10.34 show the move is short-term extended after the 6/26 expansion bar.
You’re looking at 2026-06-29 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.